Guide · Medical devices
The Medical Device Artwork Approval Process
Medical device labels, packaging and IFUs must match the technical documentation and applicable labelling requirements. This guide covers the usual approval stages, reviewers and controls for UK and EU markets. It is not regulatory advice.
- Components
- Labels, IFUs, cartons, sterile packaging
- Key elements
- Symbols, UDI, conformity marking
- Control
- Change control linked to technical file
- Cost to buyers
- Free guide, no obligation
What makes device artwork approval different?
Medical device labelling must reflect the device's technical documentation and the labelling requirements of each market, such as the EU Medical Device Regulation and the UK medical device regulations. Artwork approval needs to confirm that symbols, warnings, identifiers and conformity markings are correct for the market and the device version.
Changes to design, intended purpose, manufacturer details or markets can all trigger labelling changes, which must be assessed and controlled through your quality management system.
Typical stages of device artwork approval
- 1. Change request raised through design or document change control.
- 2. Impact assessment across labels, IFUs and packaging for each market.
- 3. Artwork creation from approved content and symbol libraries.
- 4. Proofing against approved content, including UDI and barcode checks.
- 5. Regulatory, quality and packaging engineering review.
- 6. Approval of a locked version and release to the printer.
Elements reviewers commonly check
- Device name, model and variant identifiers.
- UDI and barcode content and readability.
- Symbols, against the standard and version your procedures specify.
- Conformity marking appropriate to each market.
- Manufacturer and, where required, representative details.
- Warnings, precautions and IFU references.
Who this guide is for
- Regulatory and labelling teams at device manufacturers.
- Quality teams managing labelling change control.
- Packaging engineers and artwork coordinators.
Common failure points
- Labels not updated after a design or manufacturer change.
- Inconsistent symbols across product lines.
- UDI data on artwork not matching the master record.
- Separate UK and EU variants drifting apart.
Strengthening the process
- 01
Tie artwork to change control
Every labelling change starts from a controlled change record.
- 02
Use controlled libraries
Keep approved symbols and standard statements in one place.
- 03
Proof identifiers
Check UDI and barcode content against the master data.
- 04
Record approvals
Keep a version-specific approval record for each market.
Capabilities buyers usually look for
- Symbol and content libraries
- Reusable approved elements
- Barcode and UDI checks
- Verification against master data
- Audit trail
- Records that support your QMS
- Market variants
- Controlled UK and EU versions
Choosing support
- Software if you have internal labelling capacity.
- Outsourced labelling services if capacity is the constraint.
- Hybrid if you want external capacity inside your controlled system.
Questions to ask providers
- How do you manage symbol and statement libraries?
- Can artwork be checked against UDI master data?
- How are UK and EU variants controlled?
- What evidence supports use within our QMS?
Typical scenarios
Regulatory transition
Labels updated across a portfolio for new market requirements.
Design change
A device change triggers label and IFU updates.
New market
Market-specific marking and representative details are added.
Before changing your process
Align labelling procedures with your QMS, involve regulatory and quality early, and pilot on one product family. Confirm requirements against current official guidance for each market.
Frequently asked questions
Do UK and EU device labels need separate artwork?
Sometimes. Marking and representative requirements can differ between markets, so check current official guidance and your regulatory strategy for each product.
Is IFU approval part of the artwork process?
Usually, yes. IFUs are labelling, so they should follow the same controlled review, proofing and approval as labels and packaging.
Official guidance (external)
- Regulation (EU) 2017/745 (EUR-Lex) : EU Medical Device Regulation, including labelling and IFU requirements in Annex I.
- Regulating medical devices in the UK (GOV.UK) : MHRA guidance on placing devices on the Great Britain and Northern Ireland markets.
Requirements assessment
Get matched for medical device artwork
Tell us your products, markets and volume. A person reviews it before we suggest any provider.